30-day mortality after systemic anticancer treatment for breast and lung cancer in England: a population-based, observational study

BACKGROUND: 30-day mortality might be a useful indicator of avoidable harm to patients from systemic anticancer treatments, but data for this indicator are limited. The Systemic Anti-Cancer Therapy (SACT) dataset collated by Public Health England allows the assessment of factors affecting 30-day mor...

Descripción completa

Detalles Bibliográficos
Autores principales: Wallington, Michael, Saxon, Emma B, Bomb, Martine, Smittenaar, Rebecca, Wickenden, Matthew, McPhail, Sean, Rashbass, Jem, Chao, David, Dewar, John, Talbot, Denis, Peake, Michael, Perren, Timothy, Wilson, Charles, Dodwell, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lancet Pub. Group 2016
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5027226/
https://www.ncbi.nlm.nih.gov/pubmed/27599138
http://dx.doi.org/10.1016/S1470-2045(16)30383-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5027226/
https://www.ncbi.nlm.nih.gov/pubmed/27599138
http://dx.doi.org/10.1016/S1470-2045(16)30383-7

Ejemplares similares